Brian Higgins
17Patents
7h-index
15Co-inventors
63Inventor score
Filing activity: Oct 14, 1993 → Nov 18, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5517405A | Expert system for providing interactive assistance in solving problems such as health care management | Emerging Cross-Sectional Technologies | 493 | Expired |
| US8487772B1 | System and method for communicating information | Electricity | 20 | Active |
| US5898841A | Inter-processor communication | Electricity | 19 | Expired |
| US9486445B2 | Combination therapy for proliferative disorders | Human Necessities | 10 | Active |
| US5761412A | Multi-processor system | Physics | 9 | Expired |
| US9672535B2 | System and method for communicating information | Electricity | 7 | Active |
| US5832233A | Network coupler for assembling data frames into datagrams using intermediate-sized data parcels | Electricity | 7 | Expired |
| US9000928B2 | System and method for communicating information | Electricity | 6 | Active |
| US9324096B2 | System and method for communicating information | Electricity | 4 | Active |
| US9216170B2 | Combination therapy for proliferative disorders | Human Necessities | 3 | Active |
| US10119265B2 | Building frame connector and method of use | Fixed Constructions | 3 | Active |
| US8709419B2 | Combination therapy | Chemistry; Metallurgy | 3 | Active |
| US9956243B2 | Combination treatment for acute myeloid leukemia (AML) | Human Necessities | 1 | Active |
| US7951405B2 | Combined treatment with cisplatin and an epidermal growth factor receptor kinase inhibitor | Human Necessities | 1 | Active |
| US11382892B2 | Method for administration | Human Necessities | 0 | Active |
| US11738003B2 | Method for administration | Human Necessities | 0 | Active |
| US9295669B2 | Combination therapy for proliferative disorders | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.